An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets MET and AXL in triple-negative breast cancer

Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance

(2016) M. A. Miller et al.   Cancer Discovery

The Receptor Tyrosine Kinase AXL in Cancer Progression

(2016) Erinn Rankin et al.   Cancers

MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway

(2015) Le Kang et al.   CANCER SCIENCE

Bioinformatics Prediction andIn VitroAnalysis Revealed That miR-17 Targets Cyclin D1 mRNA in Triple Negative Breast Cancer Cells

(2015) Fariba Karami et al.   Chemical Biology & Drug Design

The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer

(2015) Xiangyan Liu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment

(2015) Parham Jabbarzadeh Kaboli et al.   PHARMACOLOGICAL RESEARCH

Predicting effective microRNA target sites in mammalian mRNAs

(2015) Vikram Agarwal et al.   eLife

The Roles of MicroRNAs in Breast Cancer

(2015) Ryou-u Takahashi et al.   Cancers

Functional Role of miR-34 Family in Human Cancer

(2013) Rui Wang et al.   CURRENT DRUG TARGETS

The receptor tyrosine kinase Axl in cancer: Biological functions and therapeutic implications

(2013) Juliano D. Paccez et al.   INTERNATIONAL JOURNAL OF CANCER

Development of a robust, low cost stem-loop real-time quantification PCR technique for miRNA expression analysis

(2013) Samira Mohammadi-Yeganeh et al.   MOLECULAR BIOLOGY REPORTS

DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows

(2013) Maria D. Paraskevopoulou et al.   NUCLEIC ACIDS RESEARCH

Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway

(2012) B. Ramaswamy et al.   CANCER RESEARCH

MicroRNAs in breast cancer initiation and progression

(2012) Huiping Liu   CELLULAR AND MOLECULAR LIFE SCIENCES

Targeting the PI3K/Akt/mTOR Pathway for Breast Cancer Therapy

(2012) Justin Cidado et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion

(2012) Laisheng Li et al.   MOLECULAR THERAPY

Targeting Axl With an High-affinity Inhibitory Aptamer

(2012) Laura Cerchia et al.   MOLECULAR THERAPY

MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1

(2012) S Yang et al.   ONCOGENE

Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA

(2011) Mark Mackiewicz et al.   BREAST CANCER RESEARCH AND TREATMENT

Axl-dependent signalling: a clinical update

(2011) Vyacheslav A. Korshunov   CLINICAL SCIENCE

miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomes

(2011) Harsh Dweep et al.   JOURNAL OF BIOMEDICAL INFORMATICS

MicroRNA history: Discovery, recent applications, and next frontiers

(2011) Maria I. Almeida et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer

(2011) G Mudduluru et al.   ONCOGENE

Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer

(2011) J. Baselga   ONCOLOGIST

An overview of the c-MET signaling pathway

(2011) Shawna Leslie Organ et al.   Therapeutic Advances in Medical Oncology

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer

(2010) Oskar W Rokhlin et al.   CANCER BIOLOGY & THERAPY

MicroRNAs and atrial fibrillation: new fundamentals

(2010) Z. Wang et al.   CARDIOVASCULAR RESEARCH

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

(2010) Dmitri Lodygin et al.   CELL CYCLE

MicroRNA function in cancer: oncogene or a tumor suppressor?

(2009) Sylvia K. Shenouda et al.   CANCER AND METASTASIS REVIEWS

Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer

(2009) J. P. Eder et al.   CLINICAL CANCER RESEARCH

Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours

(2009) Subbaya Subramanian et al.   JOURNAL OF PATHOLOGY

Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis

(2009) Y Li et al.   ONCOGENE

The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells

(2009) M Kato et al.   ONCOGENE

Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival

(2009) C. Gjerdrum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The MYCN oncogene is a direct target of miR-34a

(2008) J S Wei et al.   ONCOGENE